SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-006255
Filing Date
2022-03-15
Accepted
2022-03-15 16:31:10
Documents
14
Period of Report
2022-03-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K csbr-20220315.htm   iXBRL 8-K 40831
2 EX-99.1 csbr8-k1312022ex991xq322.htm EX-99.1 167605
6 logobranding_headerleftalia.jpg GRAPHIC 32167
  Complete submission text file 0001628280-22-006255.txt   391169

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20220315.xsd EX-101.SCH 1930
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20220315_lab.xml EX-101.LAB 22080
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20220315_pre.xml EX-101.PRE 11532
8 EXTRACTED XBRL INSTANCE DOCUMENT csbr-20220315_htm.xml XML 9804
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-11504 | Film No.: 22741560
SIC: 2836 Biological Products, (No Diagnostic Substances)